News Updates
Mesenchymal Stem Cell Therapy for COVID-19: Present or Future
Source: NCBI
“COVID-19” is the word that certainly isn’t forgotten by everybody who lives in the first half of the twenty-first century. COVID-19, as a pandemic, has led many researchers from different biomedical fields to find solutions or treatments to manage the pandemic. However, no standard treatment for this disease has been discovered to date.
Cost Of Stem Cell Therapy And Why It’s So Expensive
Source: Bioinformant
How much is stem cell therapy? According to analysis by BioInformant, the cost of stem cell therapy ranges from less than $5,000 for simple procedures to $25,000 or more for complex ones.
FDA Approves Stem Cell Trials for Coronavirus
Source: Pain News Network
As the U.S. comes to terms with the severe and often deadly consequences of the COVID-19 outbreak, novel medical interventions are being sought to stem the tide of casualties.
Stem Cell Therapy – The 10 Most Common Misconceptions Debunked
Source: News Lagoon
Stem cell therapy is a new technology, and it can alleviate joint pain, back injuries, tendon damage, ligament injuries. As scientists are studying the benefits of stem cell therapies, new and old stem cells, misbeliefs still exist.
Stem cell therapy helps patients with osteoarthritis
Source: Herald Tribune
New treatments and advances in research are giving new hope to people affected by osteoarthritis pain and symptoms. We provide stem cell therapy for osteoarthritis to help those achieve better health and live life in motion.
Pharmacist finds relief after stem cell treatment
Source: The Brunswick News
Darrell Sammons worked for years as a pharmacist and business owner. And while it didn’t seem physically demanding at the time, little movements over the years began to take their toll.
Bone Therapeutics receives Clinical Trial Application (CTA) approval for next clinical studies of its two lead candidates
Source: Street Insider
BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today announces it has received regulatory approvals for its Clinical Trial Applications for the next studies of both of its lead candidates.
